omega-n-methylarginine has been researched along with arginine vasopressin in 23 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 12,278 | 422 | 1,212 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | arginine vasopressin (IC50) |
---|---|---|---|
Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 16 (69.57) | 18.2507 |
2000's | 5 (21.74) | 29.6817 |
2010's | 2 (8.70) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katusić, ZS | 1 |
Andersson, KE; Forman, A; Garcia Pascual, A; Persson, K; Tøttrup, A | 1 |
Bolaffi, JL; Grodsky, GM; Rodd, GG; Wang, J | 1 |
Costa, A; Forsling, ML; Grossman, A; Trainer, P; Windle, R; Yasin, S | 1 |
Hidaka, H; Kajita, Y; Shibuya, M; Sugita, K; Suzuki, Y; Takayasu, M | 1 |
Evora, PR; Pearson, PJ; Schaff, HV | 1 |
Baker, CH; Price, JM; Sutton, ET; Zhou, Z | 1 |
Stallone, JN | 1 |
Ando, S; Endo, T; Hirooka, Y; Imaizumi, T; Shiramoto, M; Tagawa, T; Takeshita, A | 1 |
Melo, LG; Sonnenberg, H | 1 |
Knoers, NV; Monnens, LA; Smits, P; van Lieburg, AF | 1 |
Goto, A; Hayakawa, H; Hirata, Y; Hirobe, M; Kakoki, M; Kikuchi, K; Kimura, K; Nagano, T; Nagata, D; Omata, M; Suzuki, E; Tojo, A | 1 |
Carmines, PK; Didion, SP; Ikenaga, H; Mayhan, WG | 1 |
Mayhan, WG | 2 |
Balsam, L; Nikbakht, N | 1 |
Isoda, T; Kass, DA; Pagliaro, P; Paolocci, N; Saavedra, WF; Sunagawa, G | 1 |
Costa, A; Grossman, AB; Nappi, G; Nappi, RE; Polatti, F; Poma, A | 1 |
Chuan, P; Domenech, C; Lluch, S; Medina, P; Segarra, G; Vila, JM | 1 |
Maessen, SM; Postma, CT; Smits, P; Thien, T | 1 |
Akahoshi, M; Nagao, S; Ozeki, S; Seto, S; Tetsuo, H; Yano, K | 1 |
Aldasoro, M; Lluch, S; Martínez-León, JB; Mauricio, MD; Medina, P; Segarra, G; Vila, JM | 1 |
Bech, JN; Hansen, AB; Jensen, JM; Larsen, T; Mose, FH; Pedersen, EB | 1 |
1 trial(s) available for omega-n-methylarginine and arginine vasopressin
Article | Year |
---|---|
Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
Topics: Aged; Arginine Vasopressin; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; omega-N-Methylarginine; Pulse Wave Analysis; Pyrroles; Renal Insufficiency, Chronic; Treatment Outcome; Vascular Stiffness; Vasopressins | 2014 |
22 other study(ies) available for omega-n-methylarginine and arginine vasopressin
Article | Year |
---|---|
Endothelial L-arginine pathway and regional cerebral arterial reactivity to vasopressin.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arginine; Arginine Vasopressin; Brain Stem; Cerebral Arteries; Cerebrovascular Circulation; Dogs; Endothelium, Vascular; Female; Male; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Vasoconstrictor Agents; Vasopressins; Virulence Factors, Bordetella | 1992 |
Electrically-induced, nerve-mediated relaxation of rabbit urethra involves nitric oxide.
Topics: Animals; Arginine; Arginine Vasopressin; Dose-Response Relationship, Drug; Electric Stimulation; Endothelins; Female; In Vitro Techniques; Methylene Blue; Muscle Contraction; Muscle Relaxation; Nitric Oxide; Nitroarginine; Norepinephrine; omega-N-Methylarginine; Rabbits; Urethra | 1992 |
Interrelationship of changes in islet nicotine adeninedinucleotide, insulin secretion, and cell viability induced by interleukin-1 beta.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Arginine Vasopressin; beta-Endorphin; Cell Survival; Cells, Cultured; Colforsin; Corticosterone; Dynorphins; Glucose; Insulin; Insulin Secretion; Interleukin-1; Islets of Langerhans; Kinetics; Male; NAD; Niacinamide; Nitric Oxide Synthase; omega-N-Methylarginine; Probucol; Progesterone; Rats; Vitamin E | 1994 |
Nitric oxide modulates the release of vasopressin from rat hypothalamic explants.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Arginine Vasopressin; Hypothalamus; Male; Molsidomine; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Potassium Chloride; Rats; Rats, Wistar | 1993 |
A role of nitric oxide in vasomotor control of cerebral parenchymal arterioles in rats.
Topics: Animals; Arginine; Arginine Vasopressin; Arterioles; Cerebrovascular Circulation; In Vitro Techniques; Male; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Oxyhemoglobins; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 1994 |
Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide.
Topics: Animals; Arginine; Arginine Vasopressin; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Pulmonary Artery; Receptors, Vasopressin; Vasodilation | 1993 |
In vitro femoral arterial responses to vasoconstrictor and vasodilator agents in endotoxin shock.
Topics: Acetylcholine; Animals; Arginine; Arginine Vasopressin; Bradykinin; Femoral Artery; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Phenylephrine; Potassium Chloride; Rats; Rats, Wistar; Shock, Septic; Vasoconstrictor Agents; Vasodilator Agents | 1994 |
Role of endothelium in sexual dimorphism in vasopressin-induced contraction of rat aorta.
Topics: Animals; Aorta; Arginine; Arginine Vasopressin; Endothelium, Vascular; Female; Indomethacin; Male; Nitric Oxide; omega-N-Methylarginine; Osmolar Concentration; Phenylephrine; Rats; Rats, Sprague-Dawley; Sex Characteristics; Vasoconstriction | 1993 |
Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels.
Topics: Adult; Arginine; Arginine Vasopressin; Dose-Response Relationship, Drug; Forearm; Humans; Male; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Vasodilation | 1993 |
Effect of nitric oxide inhibition on secretion of atrial natriuretic factor in isolated rat heart.
Topics: Acetylcholine; Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; In Vitro Techniques; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley | 1996 |
Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
Topics: Adult; Arginine Vasopressin; Blood Flow Velocity; Brachial Artery; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Enzyme Inhibitors; Forearm; Humans; Hypoglycemic Agents; Male; omega-N-Methylarginine; Receptors, Vasopressin; Vasoconstrictor Agents | 1995 |
Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Desoxycorticosterone; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; Nitric Oxide; omega-N-Methylarginine; Perfusion; Piperidines; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Agents | 1997 |
Enhanced constrictor responses of skeletal muscle arterioles during chronic myocardial infarction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Arterioles; Coronary Vessels; Endothelin-1; Hemodynamics; Male; Muscle, Skeletal; Muscle, Smooth, Vascular; Myocardial Infarction; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Reference Values; Thromboxane A2; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Constrictor responses of the rat basilar artery during diabetes mellitus.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Basilar Artery; Blood Pressure; Cerebrovascular Disorders; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Thromboxanes; Vasoconstriction; Vasoconstrictor Agents | 1998 |
L-Arginine inhibits vasopressin-stimulated mesangial cell Ca2+.
Topics: Animals; Arginine; Arginine Vasopressin; Calcium; Cell Line, Transformed; Cells, Cultured; Glomerular Mesangium; Guanidine; Mice; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Spermidine; Spermine | 1998 |
Acute infusion of nicotine potentiates norepinephrine-induced vasoconstriction in the hamster cheek pouch.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Arterioles; Cheek; Cricetinae; Dose-Response Relationship, Drug; Drug Synergism; Infusions, Intravenous; Male; Mouth Mucosa; Nicotine; Nicotinic Agonists; Norepinephrine; omega-N-Methylarginine; Vasoconstriction | 1999 |
Reversal of glibenclamide-induced coronary vasoconstriction by enhanced perfusion pulsatility: possible role for nitric oxide.
Topics: Acetylcholine; Adenosine; Animals; Arginine Vasopressin; Coronary Circulation; Coronary Vessels; Dogs; Enzyme Inhibitors; Glyburide; Hypoglycemic Agents; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Potassium Channel Blockers; Pulsatile Flow; Quinacrine; Vasoconstrictor Agents | 2000 |
Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
Topics: Animals; Arginine Vasopressin; Cells, Cultured; Corticotropin-Releasing Hormone; Enzyme Inhibitors; HIV Envelope Protein gp120; Hypothalamo-Hypophyseal System; In Vitro Techniques; Male; Neurons; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Rats; Rats, Wistar | 2000 |
Increased contraction to noradrenaline by vasopressin in human renal arteries.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nifedipine; Norepinephrine; omega-N-Methylarginine; Potassium Chloride; Renal Artery; Vasoconstriction; Vasoconstrictor Agents | 2002 |
The effect of arginine vasopressin on endothelin production in the human forearm vascular bed.
Topics: Adult; Arginine Vasopressin; Case-Control Studies; Endothelins; Enzyme Inhibitors; Forearm; Humans; Infusions, Intra-Arterial; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Regional Blood Flow; Time Factors; Vasoconstrictor Agents | 2005 |
Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Desoxycorticosterone; Drinking; Eating; Enzyme Inhibitors; Ganglionic Blockers; Hexamethonium; Hypertension; Male; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Rats; Rats, Wistar; Renin; Sodium; Sodium Chloride | 2006 |
Contractile responses of human thyroid arteries to vasopressin.
Topics: Adult; Aged; Arginine Vasopressin; Arteries; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; In Vitro Techniques; Indomethacin; Male; Middle Aged; omega-N-Methylarginine; Thyroid Gland; Vasoconstriction; Vasopressins | 2013 |